Latest Reports
Diagnostic CRO Services Market - Strategic Insights and Forecasts (2026-2031)
Diagnostic development is becoming inseparable from the clinical programme it supports. Targeted therapies require validated patient-selection assays, while diagnostic manufacturers must demonstrate reproducible performance across collectio...
Dementia Diagnostics Market - Strategic Insights and Forecasts (2026-2031)
Dementia diagnosis is becoming more closely connected to the identification of underlying disease pathology, particularly as patients with cognitive symptoms are assessed for eligibility for disease-modifying Alzheimer's therapies. Structur...
Creatinine Measurement Market - Strategic Insights and Forecasts (2026-2031)
Creatinine testing is embedded in renal-function assessment, medication monitoring and routine metabolic panels, with most samples processed on established clinical chemistry systems. Demand is increasingly influenced by the quality of esti...
Contraceptives Market - Strategic Insights and Forecasts (2026-2031)
Contraceptive purchasing combines two markedly different markets: frequently replenished medicines and condoms, and longer-duration devices selected through clinical care. In pharmacies, availability, price and the ease of obtaining a presc...
Blood Lancets Market - Strategic Insights and Forecasts (2026-2031)
Blood lancets remain a routine but indispensable part of diagnostic testing, spanning household glucose checks, clinical point-of-care examinations, hemoglobin measurements and small-volume capillary collection. The commercial distinction i...
Regenerative Stem Cell Therapies Market - Strategic Insights and Forecasts (2026-2032)
Growth is becoming more closely tied to the commercial performance of licensed cellular medicines than to the number of experimental interventions advertised by clinics. Mesoblast reported US$115.2 million in RYONCIL sales for its financial...
Autoimmune Disease Testing Market - Strategic Insights and Forecasts (2026-2031)
Autoimmune disease testing brings together laboratory assays for rheumatoid arthritis, lupus, systemic sclerosis, vasculitis and related immune-mediated conditions. Demand is increasingly concentrated in laboratories able to combine antinuc...
Asia Pacific (APAC) Flu Diagnostic and Treatment Market - Strategic Insights and Forecasts (2026-2031)
Seasonal influenza testing and antiviral treatment in Asia Pacific are increasingly organized around timely identification of influenza A and B, particularly when circulating respiratory viruses produce similar clinical symptoms. The commer...
Rare Neurological Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The increasing awareness of rare neurological disorders, advancements in molecular and genetic diagnostic technologies, the rising need for early and accurate disease diagnosis, and the development of novel targeted therapies that necessita...
Norway Flu Diagnostic and Treatment Market - Strategic Insights and Forecasts (2026-2031)
Norway has a centralized, data-rich influenza surveillance and laboratory system. The Norwegian Institute of Public Health reported that more than 520,000 patients were tested for influenza during weeks 40/2024 to 34/2025, with 44,930 influ...
NGS Sample Preparation Market - Strategic Insights and Forecasts (2026-2031)
The market for NGS (Next Generation Sequencing) sample preparation is expected to grow due to developments in personalized medicine and genomic research. A crucial phase in NGS workflows is sample preparation, which includes target enrichme...
U.S. IVF Treatment Market - Strategic Insights and Forecasts (2026-2031)
The U.S. in vitro fertilization (IVF) treatment market is the largest high-value fertility-services market globally, supported by a dense network of specialist clinics, advanced embryology laboratories, broad use of genetic testing and cryo...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.